Abstract: As the impact of early albumin infusion on the prognosis of elderly individuals diagnosed with sepsis remains uncertain, this study aimed to investigate this effect in elderly patients with sepsis in the intensive care unit (ICU). We identified the information of elderly patients with sepsis requiring ICU admission from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database. They were divided into hypoalbuminemia group and control group, and the primary outcome was 90-d mortality. A multivariate logistic regression model and a multivariate Cox proportional-hazards model were used to analyze the correlation between hypoalbuminemia and patient prognosis. Kaplan-Meier survival curve and log-rank test were performed to analyze the survival outcomes. Propensity score matching (PSM) was implemented to determine the precise effect of early albumin infusion on the prognosis of elderly ICU patients with sepsis, and subgroups of patients were identified to explore the factors influencing the relationship. Early hypoalbuminemia was strongly associated with an increased risk of adverse clinical outcomes in elderly patients with sepsis in the ICU. In-hospital mortality (28.6% vs. 19.1%, P<0.001) and 90-d mortality (48.8% vs. 33.4%, P<0.001) were both significantly higher in the early hypoalbuminemia group than in the control group. PSM analysis showed that early albumin infusion was associated with lower in-hospital mortality and 90-d mortality in elderly patients with sepsis combined with hypoalbuminemia in the ICU. Early infusion of albumin could improve patient prognosis and reduce in-hospital mortality and 90-d mortality.

早期白蛋白输注与老年脓毒症患者死亡率间的关系--基于MIMIC-IV数据库分析

[1]AngusDC, van der PollT, 2013. Severe sepsis and septic shock. N Engl J Med, 369(9):840-851.

[2]Arnau-BarrésI, Güerri-FernándezR, LuqueS, et al., 2019. Serum albumin is a strong predictor of sepsis outcome in elderly patients. Eur J Clin Microbiol Infect Dis, 38(4):743-746.

[3]BunnF, TrivediD, 2012. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev, 2012(7):CD001319.

[4]CaironiP, TognoniG, MassonS, et al., 2014. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med, 370(15):1412-1421.

[5]ChengBL, LiZW, WangJY, et al., 2017. Comparison of the performance between sepsis-1 and sepsis-3 in ICUs in China: a retrospective multicenter study. Shock, 48(3):301-306.

[6]DellingerRP, CarletJM, MasurH, et al., 2004. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med, 30(4):536-555.

[7]DuboisMJ, Orellana-JimenezC, MelotC, et al., 2006. Albumin administration improves organ function in critically ill hypoalbuminemia patients: a prospective, randomized, controlled, pilot study. Crit Care Med, 34(10):2536-2540.

[8]El-SharkawyAM, SahotaO, MaughanRJ, et al., 2014. The pathophysiology of fluid and electrolyte balance in the older adult surgical patient. Clin Nutr, 33(1):6-13.

[9]FanaliG, di MasiA, TrezzaV, et al., 2012. Human serum albumin: from bench to bedside. Mol Aspects Med, 33(3):209-290.

[10]Fleischmann-StruzekC, MellhammarL, RoseN, et al., 2020. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med, 46(8):1552-1562.

[11]FurukawaM, KinoshitaK, YamaguchiJ, et al., 2019. Sepsis patients with complication of hypoglycemia and hypoalbuminemia are an early and easy identification of high mortality risk. Intern Emerg Med, 14(4):539-548.

[12]GaieskiDF, MikkelsenME, BandRA, et al., 2010. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med, 38(4):1045-1053.

[13]Garcia-MartinezR, CaraceniP, BernardiM, et al., 2013. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology, 58(5):1836-1846.

[14]GattaA, VerardoA, BolognesiM, 2012. Hypoalbuminemia. Intern Emerg Med, 7(Suppl 3):193-199.

[15]GilesS, CzuprynskiC, 2003. Novel role for albumin in innate immunity: serum albumin inhibits the growth of Blastomyces dermatitidis yeast form in vitro. Infect Immun, 71(11):6648-6652.

[16]HaririG, JoffreJ, DeryckereS, et al., 2018. Albumin infusion improves endothelial function in septic shock patients: a pilot study. Intensive Care Med, 44(5):669-671.

[17]HuJ, LvCW, HuXX, et al., 2021. Effect of hypoproteinemia on the mortality of sepsis patients in the ICU: a retrospective cohort study. Sci Rep, 11(1):24379.

[18]JoannidisM, WiedermannCJ, OstermannM, 2022. Ten myths about albumin. Intensive Care Med, 48(5):602-605.

[19]JonesAE, BrownMD, TrzeciakS, et al., 2008. The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. Crit Care Med, 36(10):2734-2739.

[20]KendallH, AbreuE, ChengAL, 2019. Serum albumin trend is a predictor of mortality in ICU patients with sepsis. Biol Res Nurs, 21(3):237-244.

[21]LewisSR, PritchardMW, EvansDJ, et al., 2018. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev, 8(8):CD000567.

[22]MayrFB, YendeS, Linde-ZwirbleWT, et al., 2010. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA, 303(24):2495-2503.

[23]MilfordEM, ReadeMC, 2019. Resuscitation fluid choices to preserve the endothelial glycocalyx. Crit Care, 23:77.

[24]MontealegreF, LyonsBM, 2021. Fluid therapy in dogs and cats with sepsis. Front Vet Sci, 8:622127.

[25]NicholsonJP, WolmaransMR, ParkGR, 2000. The role of albumin in critical illness. Br J Anaesth, 85(4):599-610.

[26]PhilipsCA, MaiwallR, SharmaMK, et al., 2021. Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis-induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial. Hepatol Int, 15(4):983-994.

[27]RamadoriG, 2021. Albumin infusion in critically ill COVID-19 patients: hemodilution and anticoagulation. Int J Mol Sci, 22(13):7126.

[28]SchuetzP, WolbersM, Christ-CrainM, et al., 2010. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care, 14(3):R106.

[29]SeymourCW, LiuVX, IwashynaTJ, et al., 2016. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA, 315(8):762-774.

[30]SeymourCW, KennedyJN, WangS, et al., 2019. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA, 321(20):2003-2017.

[31]SingerM, DeutschmanCS, SeymourCW, et al., 2016. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA, 315(8):801-810.

[32]SivayohamN, BlakeLA, TharimoopantavidaSE, et al., 2020. Treatment variables associated with outcome in emergency department patients with suspected sepsis. Ann Intensive Care, 10:136.

[33]SoetersPB, WolfeRR, ShenkinA, 2019. Hypoalbuminemia: pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr, 43(2):181-193.

[34]StanojcicM, ChenP, XiuF, et al., 2016. Impaired immune response in elderly burn patients: new insights into the immune-senescence phenotype. Ann Surg, 264(1):195-202.

[35]TidswellR, Inada-KimM, SingerM, 2021. Sepsis: the importance of an accurate final diagnosis. Lancet Respir Med, 9(1):17-18.

[36]VincentJL, DuboisMJ, NavickisRJ, et al., 2003. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg, 237(3):319-334.

[37]VincentJL, RussellJA, JacobM, et al., 2014. Albumin administration in the acutely ill: what is new and where next? Crit Care, 18(4):231.

[38]WigmoreGJ, AnsteyJR, St JohnA, et al., 2019. 20% Human albumin solution fluid bolus administration therapy in patients after cardiac surgery (the HAS FLAIR study). J Cardiothorac Vasc Anesth, 33(11):2920-2927.

[39]YamaguchiJ, KinoshitaK, IharaS, et al., 2018. The clinical significance of low serum arachidonic acid in sepsis patients with hypoalbuminemia. Intern Med, 57(13):1833-1840.